Investors & Media

Latest Presentations and Publications

Scientific Presentations
Scientific Publications

Latest Presentations

All Presentations

Sangamo Corporate Presentation

Mar 13, 2024

Sangamo Corporate Presentation 7.7 MB

Corporate Call and Q4 Update

Mar 13, 2024

Corporate Call and Q4 Update 6.2 MB

Source WORLDSymposium™ 2024

Isaralgagenecivaparvovec(ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR)

Feb 05, 2024

Isaralgagenecivaparvovec(ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR) 1.2 MB

Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR)

Feb 05, 2024

Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR) 3.2 MB

Source ASH Presentation

Four-Year Follow-up of the Alta Study, a Phase 1/2 Study of GiroctocogeneFitelparvovec(PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A

Dec 12, 2023

Four-Year Follow-up of the Alta Study, a Phase 1/2 Study of GiroctocogeneFitelparvovec(PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A 888.6 KB

Source ESGCT 2023

Shank3 Gene Activation Mediated by Zinc Finger Activators (ZF-As) as a Therapeutic Approach for Phelan-McDermid Syndrome

Oct 24, 2023

Shank3 Gene Activation Mediated by Zinc Finger Activators (ZF-As) as a Therapeutic Approach for Phelan-McDermid Syndrome 7.9 MB

Source ESGCT 2023

Zinc Finger Activators restore normal gene and protein expression in a mouse model of SCN2A haploinsufficiency

Oct 24, 2023

Zinc Finger Activators restore normal gene and protein expression in a mouse model of SCN2A haploinsufficiency 4 MB

Source Prion 2023 Conference

Neuron-SpecifiExpression of Zinc-Finger Repressors Mediate Widespread Prion Reduction in the Brain for the Potential Treatment of Prion Disease

Oct 20, 2023

Prion 2023 Conference 1.9 MB

Source 17th Annual Pain Therapeutic Summit

Zinc finger mediated epigenetic repression of SCN9A gene as a therapeutic approach for painful peripheral neuropathies

Oct 19, 2023

17th Annual Pain Therapeutic Summit 9.1 MB

Source ASGCT 2023 Presentation

Fitness Maturation of Engineered AAV Capsid STAC-102 Enhances Central Nervous System Transduction after CSF Administration in Cynomolgus Macaques

May 19, 2023

Fitness Maturation of Engineered AAV Capsid STAC-102 Enhances Central Nervous System Transduction after CSF Administration in Cynomolgus Macaques 15.5 MB

Source ASGCT 2023 Presentation

Evolution of blood-brain barrier penetrant AAV capsids in non-human primates using a multiplexed transcription dependent capsid engineering platform

May 19, 2023

Evolution of blood-brain barrier penetrant AAV capsids in non-human primates using a multiplexed transcription dependent capsid engineering platform 6.1 MB

Latest Publications

All Presentations

More information is coming soon.